Dear ECCMID Participant,

We regret that due to COVID-19 we will not attend ECCMID 2021 in person this year. However we can tell you here how New England Biolabs is able to support your research, development and manufacturing needs for infectious disease diagnostics, so please read on!

Tools for Point-of-Care and Lab-based Diagnostics –
Partner with an Industry leader

NEB is a privately-held company that routinely partners with customers to support diagnostic workflows with innovative products and service offerings. Our extensive portfolio includes products for qPCR/RT-qPCR, isothermal amplification, sample preparation for next generation sequencing, and nucleic acid purification. We have made significant investment in our scale up and manufacturing capabilities and can provide sufficient material to accommodate millions of samples, across multiple platforms.

Featured products include:

High concentration mix supports increased sample input for detection sensitivity.

For real-time detection of SARS-CoV-2 nucleic acid using hydrolysis probes.

Visually observe nucleic acid amplification with a pink-to-yellow color change.

For colorimetric detection of amplification of SARS-CoV-2 nucleic acid.

If you are looking for reagents manufactured under ISO 13485 accreditation to incorporate into your latest technologies, Laboratory Developed Tests (LDT), CE/IVD molecular diagnostic kits compliant with IVDR, EUA or 510K approval, NEB is your partner for assay development and scale up needs.

Compatible with multiple amplification detection methods including real-time fluorescence.

Does this sound interesting to you?

Our business development team wants to hear about your project and discuss how NEB can support you. Please contact us!

Euan Forbes eforbes@neb.com

Kiran Gulati gulati@neb.com